Conference
Individual lifetime benefit from low-dose colchicine in patients with chronic coronary artery disease
Abstract
AIMS: Low-dose colchicine reduces cardiovascular risk in patients with coronary artery disease (CAD), but absolute benefits may vary between individuals. This study aimed to assess the range of individual absolute benefits from low-dose colchicine according to patient risk profile.
METHODS AND RESULTS: The European Society of Cardiology (ESC) guideline-recommended SMART-REACH model was combined with the relative treatment effect of low-dose …
Authors
Burger PM; Dorresteijn JAN; Fiolet ATL; Koudstaal S; Eikelboom JW; Nidorf SM; Thompson PL; Cornel JH; Budgeon CA; Westendorp ICD
Volume
30
Pagination
pp. 1950-1962
Publisher
Oxford University Press (OUP)
Publication Date
December 21, 2023
DOI
10.1093/eurjpc/zwad221
Conference proceedings
European Journal of Preventive Cardiology
Issue
18
ISSN
2047-4873